Pfizer boosts COVID shot forecasts by $2 billion

Pfizer boosts COVID shot forecasts by $2 billion

on Also in , , ,
Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations.

Share:

Previous
Next

Comentarios

Publicar un comentario

Leave a comment. Thanks!

Comentarios de Facebook

Suscribirse a: Enviar comentarios (Atom)